Ch. 36 AAV Flashcards
AAVs
(4) GPA, MPA, EGPA, Renal-limited pauci-immune GN
AAVs and associated ANCAs
EGPA: pANCA > cANCA
cANCA (PR3-ANCA): GPA>MPA>EGPA
pANCA (MPO-ANCA): MPA>GPA
Heterogenous group of antibodies that bind to antigens in the primary granules of neutrophils and lysosomes of monocytes
ANCAs
ANCAs are present in what vascuitides
AAVs
Renal-limited vasculitis
Certain drug-induced vasculitis syndromes
GPA triad
Upper respiratory tract inflamm
Lower respiratory tract inflamm
Renal disease
Genes associated with GPA
MHC Class II HLA-DP region
Environmental factors identified as triggers for GPA
Infections (S. aureus, other respi tract infections)
Drugs (PTU, hydralazine, minocycline)
Silica dust
Key effector cells of endothelial injury in GPA
Primed neutrophils activated by ANCA
Other players in the inflammatory loop of GPA besides primed neutrophils
Alternative complement pathways, autoantibodies, cellular immunity
MC features of GPA at onset
Renal > pulmonary > ENT
Limited or localized GPA is defined by
Absence of renal disease
ACR criteria for GPA
2/4
1. Nasal/oral inflammation
2. Abnormal cxr
3. Abnormal ua
4. Granulomatous inflammation
EULAR/PRINTO/PRES criteria for GPA
3/6
1. Upper airway involvement
2. LTB stenosis
3. Pulmonary involvement
4. Renal involvement
5. Granulomatous inflamm
6. ANCA positivity
Classic presentation of GPA
Pulmo hem + GN (pulmo-renal syndrome)
Condition wherein tissue diagnosis is desirable in GPA
Single organ involvement
AAV where there is pauci-immune GN and characteristic serology (elevated ANCA)
GPA
GPA vs MPA
GPA: Upper airway disease
MC clinical manifestations in children with GPA
Constitutional > Renal > Pulmonary
T/F Upper respi tract biopsy in patients with GPA have very high yield
F, disappointingly low
T/F Standard inflamm markers are helpful in determining level of disease activity in GPA
F
Useful markers to track inflammation in GPA
S100A8/A9
S100A12
Neutrophil count
Pathologic characteristic of GPA
Granulomata
T/F Presence of eosinophils in small numbers indicate EGPA instead of GPA
F, small numbers of eosinophils may be seen in GPA and EGPA is characterized by large numbers of eos
MC reported renal lesion of GPA
Renal granulomata are RARE; Extracapillary proliferation and crescent formation in a focal and segmental pattern; IF shows pauci-immune pattern
T/F GPA is usually monophasic
F, follow a chronic relapsing course
Usual duration of treatment of GPA
3-6m induction, 2-4y maintenance
Cornerstone of therapy for remission induction and maintenance in GPA
Corticosteroids
Induction therapy for GPA
MILD: Prednisone 1-2mkday or SEVERE: MPPT 30mkdose for 3 days IV
PLUS
CYC or MTX
Target dose for corticosteroid used in GPA induction
0.2mkday or 10mg/day whichever is lower by 6th month (induction) to be continued until 12 months (maintenance phase)
T/F For GPA patients who do not respond well to IV CYC, patient may be shifted to oral CYC
T
Indications for RTX as induction in GPA
- Failed CYC
- Relapsing disease
- CYC toxicity
Options for maintenance therapy for GPA
Pred +
AZA or MTX or RTX
for minimum of 18m to 24m
Standard of care for remission maintenance in adults with AAV
AZA
Alternative to AZA for remission maintenance in AAV
MTX
Option for refractory GPA
RTX
For pedia GPA, there is an increasingly high rate of ___ involvement accumulating with time
ENT
AAV originally described as a subset of PAN
MPA
AAV: Necrotizing GN
MPA
Necrotizing vasculitis with few or no immune deposits, predominantly affecting small vessels
MPA
GPA vs MPA: No strong assoc with infection
MPA
MC pulmo manifestation of MPA
Pulmo hem
Predominant skin presentation in MPA
PUrpura
GPA vs MPA: Pulmo manif are more common
GPA
MC clinical features of MPA
Same with GPA:
Constitutional > renal > pulmo
MC constitutional symptoms for both GPA and MPA
Malaise/fatigue > fever > wt loss
MC renal manif for both GPA and MPA
Biopsy-proven nephritis
MC msk manif for both GPA and MPA
Arthralgia/arthritis
The only ENT manif reported for MPA
Oral ulcer
MC CNS manif for both GPA and MPA
severe headache
MC GI manif for both GPA and MPA
Nonspecific abdominal pain
MC cutaneous manif for both GPA and MPA
Palpable purpura
GPA vs MPA: Pulmonary capillaritis
MPA
GPA vs MPA: Pulmo nodules
GPA
MPA vs anti-GBM disease
Anti-GBM: IF showing linear deposition of IgG along GBM
GPA vs MPA
GPA:
Granulomatous inflamm
URT involvement partic nasal septal perforation and/or saddle nose deformity
Nodules instead of capillaritis
T/F Anti-GBM disease may also present with ANCA
T
Treatment for MPA
Similar to other AAVs: CS + CYC, RTX
EGPA vasculitis commonly involves what organ systems
CV
CNS
GI
Eosinophil-rich granulomatous inflamm of the respi tract
EGPA
Main ANCA seen in EGPA
MPO ANCA
ACR EGPA criteria
At least 4 of the ff:
Asthma
Eosinophilia (>10% of diff count)
History of allergy
Mono- or polyneuropathy
Pulmonary infiltrates
Paranasal sinus abn
Extravascular eosinophils
3 phases of EGPA that DO NOT usually occur sequentially
1) Asthma and other allergic manifestations
2) Eosinophilic phase: Eosinophilia + Pulmo infiltrates
3) Vasculitis
MC presenting symptom of EGPA
Asthma > nonfixed pulmo infiltrates > sinusitis > skin
Hallmark of EGPA
Asthma
T/F Asthma of EGPA usually requires CS for treatment
T
T/F Renal disease of EGPA is usually mild and rarely progresses
T
T/F HRCT of lung is recommended if suspicion of EGPA is high
T, CXR may be normal in the presence of lung disease
Treatment for EGPA
Like other AAVs (GPA and MPA)
T/F EGPA usually has a prolonged prodromal course of many years
T